AI-generated summary
In a study of 30 patients receiving radiotherapy for head and neck cancer, the authors report that photobiomodulation therapy did not significantly reduce salivary flow rate and showed no difference in xerostomia, with several salivary trace element concentrations changing. The authors conclude that the therapy prevented a significant decline in salivary flow, though the abstract does not report a control group for comparison.
- Participants
- 30
- Who or what was studied
- Patients undergoing radiotherapy (65 Gy) for head and neck cancer, average age 60.7 years
- Limits stated in the abstract
- The abstract reports a single-group pre- and post-treatment design with no control group, and the stated conclusion that PBMT prevented salivary flow reduction is not clearly supported by the reported results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.